Lakeside Holding Acquires Hupan Pharmaceutical (Hubei) to Enter Medical Logistics in China
November 11, 2024
Lakeside Holding Limited, through its wholly owned subsidiary Sichuan Hupan, entered into an equity transfer agreement to acquire Hupan Pharmaceutical (Hubei) Co., Ltd. for RMB 4.0 million (US$0.6 million). The acquisition is expected to add approximately US$7 million in annual revenue and expands Lakeside’s capabilities into China’s medical logistics sector.
- Buyers
- Lakeside Holding Limited, Sichuan Hupan Jincheng Enterprise Management Co., Ltd.
- Targets
- Hupan Pharmaceutical (Hubei) Co., Ltd.
- Industry
- Healthcare Services
- Location
- Hubei, China
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
HUTCHMED Divests 45% Stake in Shanghai Hutchison Pharmaceuticals to GP Health Service Capital and Shanghai Pharmaceuticals Holding
January 3, 2025
Pharmaceuticals
HUTCHMED agreed to sell a 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for about US$608 million in cash to GP Health Service Capital Co. and Shanghai Pharmaceuticals Holding. The divestment allows HUTCHMED to reallocate capital to its core oncology and ATTC (antibody-targeted therapy conjugate) pipeline and accelerate its path to profitability.
-
Huons Acquires 31.5% Stake in PanGen Biotech to Build Biopharma CDMO Capability
November 5, 2024
Biotechnology
Huons Co., Ltd. agreed to acquire 2,647,378 shares and newly issued shares in PanGen Biotech Inc. for KRW 14.3 billion, taking a 31.53% stake and becoming PanGen's largest shareholder with plans to secure management control and incorporate PanGen as a subsidiary. The deal is intended to strengthen Huons' biopharmaceutical R&D and CDMO manufacturing capabilities, including securing GMP production for human-derived hyaluronidase used to enable subcutaneous delivery of biologics.
-
Healthcare Holding Switzerland Acquires Schaublin Medica SA
April 15, 2025
Medical Devices
Healthcare Holding Switzerland AG has acquired 100% of Schaublin Medica SA from its founders as part of a succession plan. Schaublin Medica, based in Plan-les-Ouates, specializes in distribution of vascular grafts, endoprostheses, stents and drug‑coated balloon catheters to hospitals across Switzerland and will join Healthcare Holding's medical-technology platform to expand product and service offerings.
-
Linden Capital Partners Acquires LifeStyles Healthcare
December 1, 2022
Consumer Products
Linden Capital Partners has acquired LifeStyles Healthcare, a global sexual health and wellness platform, from a consortium of investors including Trustar Capital and Humanwell Healthcare. The deal excludes LifeStyles' Chinese operations (including the Jissbon brand), which will be retained by the selling shareholders; Linden has named Laurent Faracci as incoming CEO and Ron Fugate as Chairman to drive commercial, brand, and innovation-led growth.
-
Andlauer Healthcare Group Acquires Logistics Support Unit (LSU) Inc.
March 1, 2022
Logistics & Distribution
Andlauer Healthcare Group Inc. (AHG) has completed its acquisition of 100% of Logistics Support Unit (LSU) Inc. for approximately $30 million, paid via the issuance of 154,639 subordinate voting shares and about $22.5 million in cash. LSU is a Canada-based third-party logistics provider specializing in pharmaceutical, medical and biotechnology warehousing, distribution and order management and is the exclusive distributor of immunizing agents for Québec's public health system.
-
Healthcare Holding Schweiz Acquires Majority Stake in Medddbase International
January 6, 2026
Healthcare Services
Healthcare Holding Schweiz AG has acquired a majority interest in Medddbase International AG (including Medddbase Schweiz AG and Medddbase Deutschland GmbH). The acquisition brings Medddbase's medtech commercialization, logistics, warehousing and Swiss/EU importer and regulatory services into Healthcare Holding's buy-build platform, strengthening its distribution and market-access capabilities across Switzerland, the EU and the UK.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.